GT Biopharma
(NASDAQ) GTBP
GT Biopharma Financials at a Glance
Market Cap
$18.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$47.73M
EPS (TTM)
-$14.40
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$0.43
Volume
1,043,291
Open
$0.45
Price
$0.43
Volume
1,043,291
Open
$0.45
Previous Close
$0.43
Daily Range
$0.41 - $0.46
52-Week Range
$0.26 - $2.29
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$0.43
Volume
1,043,291
Open
$0.45
Previous Close
$0.43
Daily Range
$0.41 - $0.46
52-Week Range
$0.26 - $2.29
Estimated Earnings Date
Aug 13, 2026
GTBP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GT Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Michael Breen
Website
www.gtbiopharma.comHeadquarters
San Francisco, CA 94005, US
GTBP Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-901.32%
Return on Capital
-214.65%
Return on Assets
-477.53%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
-0.48%
Stock Overview
Market Cap
$18.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
44.34M
Volume
1.04M
Avg. Volume
1.48M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$13.34M
EBITDA
-$46.04M
Operating Cash Flow
-$13.18M
Capital Expenditure
$0.00
Free Cash Flow
-$13.18M
Cash & ST Invst.
$8.92M
Total Debt
$0.00
GT Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$18.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$18.84M
N/A
Employees
1
N/A
Net Income
-$2.83M
-265.1%
EBITDA
-$2.77M
-257.0%
Quarterly Fundamentals
Total Cash
$8.92M
+277.3%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-4.78%
N/A
Return on Invested Capital
-1.76%
N/A
Free Cash Flow
-$2.47M
-12.1%
Operating Cash Flow
-$2.47M
-12.1%